Colorectal cancer screening has a large potential to reduce incidence and mortality, and screening programmes have been implemented in many countries and regions. Emerging epidemiological trends and evidence on the effectiveness and cost-effectiveness of various screening options call for regular updates of screening recommendations.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021).
Siegel, R. L. et al. Colorectal cancer statistics, 2020. CA Cancer J. Clin. 70, 145–164 (2020).
Jeon, J. et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology 154, 2152–2164 (2018).
Peterse, E. F. P. et al. Comparing the cost-effectiveness of innovative colorectal cancer screening tests. J. Natl Cancer Inst. 113, 154–161 (2021).
Brenner, H., Stock, C. & Hoffmeister, M. In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening. J. Clin. Epidemiol. 66, 1144–1150 (2013).
Shaukat, A. et al. Long-term mortality after screening for colorectal cancer. N. Engl. J. Med. 369, 1106–1114 (2013).
Brenner, H., Stock, C. & Hoffmeister, M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 348, g2467 (2014).
Buskermolen, M. et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. BMJ 367, l5383 (2019).
Gies, A., Cuk, K., Schrotz-King, P. & Brenner, H. Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening. Gastroenterology 154, 93–104 (2018).
Gruner, L. F. et al. The effects of different invitation schemes on the use of fecal occult blood tests for colorectal cancer screening: systematic review of randomized controlled trials. Cancers 13, 1520 (2021).
The authors declare no competing interests.
About this article
Cite this article
Brenner, H., Hoffmeister, M. Striving to optimize colorectal cancer prevention. Nat Rev Gastroenterol Hepatol 18, 677–678 (2021). https://doi.org/10.1038/s41575-021-00494-6